2H,10H-Indolo[2,1-c]pyrazino[1,2-a][1,4]benzodiazepine-16-carboxylicacid, 1,3,4,16b-tetrahydro-2-methyl-, methyl ester (115313-22-9)

Identification
Name:	2H,10H-Indolo[2,1-c]pyrazino[1,2-a][1,4]benzodiazepine-16-carboxylicacid, 1,3,4,16b-tetrahydro-2-methyl-, methyl ester
Synonyms:	CPDD 0035;Serazapine
CAS:	115313-22-9
Molecular Formula:	C22H23 N3 O2
Molecular Weight:	361.443
InChI:	InChI=1/C22H23N3O2/c1-23-11-12-24-17-9-5-3-7-15(17)13-25-18-10-6-4-8-16(18)20(22(26)27-2)21(25)19(24)14-23/h3-10,19H,11-14H2,1-2H3
Molecular Structure:
Properties
Flash Point:	294.3°C
Boiling Point:	563.1°C at 760 mmHg
Density:	1.29g/cm³
Refractive index:	1.677
Flash Point:	294.3°C
Safety Data

Other Product

2H,10H-Indolo[2,1-c]pyrazino[1,2-a][1,4]benzodiazepine-16-carboxylicacid, 1,3,4,16b-tetrahydro-2-methyl-, methyl ester, hydrochloride (1:1)
Pyrazino[1,2-a][1,4]benzodiazepine-4-carboxylicacid, 9-chloro-7-(2-chlorophenyl)-1,2,3,5-tetrahydro-1-methyl-2-oxo-, methylester
2H,10H-Pyrazino[1,2-a]pyrrolo[2,1-c][1,4]benzodiazepine,1,3,4,14b-tetrahydro-2-methyl-
5H-Indolo[3''',2''':4'',5'']azocino[1'',2'':4',5']pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-10,18(6H,10aH)-dione,11,11a,16,16a-tetrahydro-11a-hydroxy-6,6-dimethyl-16-(3-methyl-2-buten-1-yl)-,(10aR,11aR,16aS)-
Yohimban-16-carboxylicacid,21-[(2S,3R,12bS)-3-ethyl-1,2,3,4,6,7,12,12b-octahydro-8-hydroxy-2-[(1E)-2-methoxy-1-(methoxymethylene)-2-oxoethyl]indolo[2,3-a]quinolizin-9-yl]-17-hydroxy-,methyl ester, (3b,16b,17b,21b)- (9CI)
1H-1,5-Benzodiazepine-2-carboxylicacid, 2,3,4,5-tetrahydro-4-methyl-5-[2-(1-piperidinyl)acetyl]-, ethyl ester
Yohimban-16-carboxylicacid,18-[[(2E)-3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2-propenyl]oxy]-11,17-dimethoxy-,methyl ester, (3b,16b,17a,18b,20a)- (9CI)
1H-1,5-Benzodiazepine-2-carboxylicacid, 2,3,4,5-tetrahydro-4-methyl-5-(1-oxobutyl)-, ethyl ester
4H-1,4-Benzodiazepine-4-carboxylicacid, 7-chloro-1,2,3,5-tetrahydro-1-methyl-3-(1-methylethyl)-2-oxo-,1,1-dimethylethyl ester
5H-Indolo[3''',2''':4'',5'']azocino[1'',2'':4',5']pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-10,18(6H,10aH)-dione,16-(1,1-dimethyl-2-propen-1-yl)-11,11a,16,16a-tetrahydro-11a-hydroxy-6,6-dimethyl-,(10aR,11aR,16aS)-
Yohimban-16-carboxylicacid,1-[2-(diethylamino)ethyl]-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-,methyl ester, (3b,16b,17a,18b,20a)-
9H,11H-Pyrazino[2,1-c]pyrrolo[1,2-a][1,4]benzodiazepine,12,13,14,14a-tetrahydro-13-(2-propen-1-yl)-
1H-1,5-Benzodiazepine-2-carboxylicacid, 2,3,4,5-tetrahydro-2-methyl-5-(1-oxo-3-phenyl-2-propen-1-yl)-4-phenyl-,ethyl ester
Yohimban-16-carboxylicacid,11,17-dimethoxy-18-[[(2E)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propen-1-yl]oxy]-,methyl ester, (3b,16b,17a,18b,20a)-
Indolo[3'',2'':4',5']pyrrolo[2',1':3,4]pyrazino[2,1-b]quinazoline-5,8(7H,9aH)-dione,14b-(1,1-dimethyl-2-propen-1-yl)-10,14b,15,15a-tetrahydro-7-methyl-,(7R,9aS,14bR,15aS)-
Indolo[3'',2'':4',5']pyrrolo[2',1':3,4]pyrazino[2,1-b]quinazoline-5,8(7H,9aH)-dione,10-acetyl-14b-(1,1-dimethyl-2-propen-1-yl)-10,14b,15,15a-tetrahydro-7-methyl-,(7R,9aR,14bR,15aS)-
10H-Thieno[2,3-b][1,5]benzodiazepine,2-methyl-4-(4-methyl-4-oxido-1-piperazinyl)-
10H-Thieno[2,3-b][1,5]benzodiazepine,7-fluoro-2-(1-methylethyl)-4-(4-methyl-1-piperazinyl)-
1H-Indolo[3,2,1-de][1,5]naphthyridine-6-carboxylicacid, 3-ethyl-2,3,3a,4-tetrahydro-, methyl ester, hydrochloride (1:1)
10H-Thieno[2,3-b][1,5]benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-